Name | Number of supported studies | Average coverage | |
|---|---|---|---|
| peripheral blood | 19 studies | 50% ± 13% | |
| lung | 18 studies | 40% ± 14% | |
| brain | 16 studies | 33% ± 15% | |
| intestine | 10 studies | 27% ± 9% | |
| kidney | 8 studies | 32% ± 15% | |
| eye | 8 studies | 42% ± 17% | |
| bone marrow | 5 studies | 31% ± 12% | |
| pancreas | 4 studies | 43% ± 19% | |
| placenta | 4 studies | 42% ± 21% | |
| uterus | 4 studies | 52% ± 7% | |
| lymph node | 4 studies | 44% ± 9% | |
| breast | 4 studies | 34% ± 9% | |
| liver | 4 studies | 45% ± 16% | |
| heart | 3 studies | 21% ± 5% | |
| adipose | 3 studies | 27% ± 14% | |
| adrenal gland | 3 studies | 30% ± 12% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
|---|---|---|---|---|---|---|
| intestine | 100% | 6457.93 | 966 / 966 | 100% | 150.40 | 526 / 527 |
| ovary | 100% | 4466.00 | 180 / 180 | 100% | 153.21 | 429 / 430 |
| thymus | 100% | 5219.80 | 652 / 653 | 100% | 248.55 | 604 / 605 |
| brain | 100% | 6720.09 | 2633 / 2642 | 100% | 227.38 | 705 / 705 |
| breast | 100% | 8144.17 | 459 / 459 | 100% | 263.04 | 1114 / 1118 |
| prostate | 100% | 6008.81 | 244 / 245 | 100% | 296.30 | 502 / 502 |
| lung | 100% | 7875.64 | 577 / 578 | 100% | 189.69 | 1151 / 1155 |
| adrenal gland | 100% | 9740.87 | 258 / 258 | 99% | 223.18 | 228 / 230 |
| uterus | 100% | 6287.14 | 170 / 170 | 99% | 137.70 | 455 / 459 |
| stomach | 99% | 4572.57 | 357 / 359 | 100% | 149.12 | 285 / 286 |
| bladder | 100% | 6858.38 | 21 / 21 | 99% | 154.43 | 497 / 504 |
| kidney | 98% | 3821.75 | 87 / 89 | 100% | 253.79 | 899 / 901 |
| esophagus | 100% | 6024.98 | 1444 / 1445 | 97% | 99.25 | 178 / 183 |
| skin | 99% | 5525.06 | 1786 / 1809 | 97% | 225.98 | 458 / 472 |
| pancreas | 91% | 2483.79 | 299 / 328 | 99% | 202.15 | 177 / 178 |
| liver | 75% | 1544.99 | 169 / 226 | 86% | 66.67 | 348 / 406 |
| adipose | 100% | 9095.23 | 1204 / 1204 | 0% | 0 | 0 / 0 |
| blood vessel | 100% | 12710.55 | 1335 / 1335 | 0% | 0 | 0 / 0 |
| lymph node | 0% | 0 | 0 / 0 | 100% | 229.38 | 29 / 29 |
| spleen | 100% | 5572.85 | 241 / 241 | 0% | 0 | 0 / 0 |
| tonsil | 0% | 0 | 0 / 0 | 100% | 130.40 | 45 / 45 |
| ureter | 0% | 0 | 0 / 0 | 100% | 83.36 | 1 / 1 |
| muscle | 100% | 8871.01 | 802 / 803 | 0% | 0 | 0 / 0 |
| heart | 97% | 8579.53 | 833 / 861 | 0% | 0 | 0 / 0 |
| peripheral blood | 95% | 6926.83 | 885 / 929 | 0% | 0 | 0 / 0 |
| eye | 0% | 0 | 0 / 0 | 83% | 82.82 | 66 / 80 |
| abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| GO_0072659 | Biological process | protein localization to plasma membrane |
| GO_0032874 | Biological process | positive regulation of stress-activated MAPK cascade |
| GO_0007611 | Biological process | learning or memory |
| GO_0015813 | Biological process | L-glutamate transmembrane transport |
| GO_0098712 | Biological process | L-glutamate import across plasma membrane |
| GO_0043280 | Biological process | positive regulation of cysteine-type endopeptidase activity involved in apoptotic process |
| GO_0051051 | Biological process | negative regulation of transport |
| GO_0034599 | Biological process | cellular response to oxidative stress |
| GO_0010917 | Biological process | negative regulation of mitochondrial membrane potential |
| GO_0015031 | Biological process | protein transport |
| GO_0008631 | Biological process | intrinsic apoptotic signaling pathway in response to oxidative stress |
| GO_0043065 | Biological process | positive regulation of apoptotic process |
| GO_0071407 | Biological process | cellular response to organic cyclic compound |
| GO_0006749 | Biological process | glutathione metabolic process |
| GO_0002037 | Biological process | negative regulation of L-glutamate import across plasma membrane |
| GO_0005856 | Cellular component | cytoskeleton |
| GO_0005886 | Cellular component | plasma membrane |
| GO_0016020 | Cellular component | membrane |
| GO_0005789 | Cellular component | endoplasmic reticulum membrane |
| GO_0099523 | Cellular component | presynaptic cytosol |
| GO_0005515 | Molecular function | protein binding |
| GO_0003674 | Molecular function | molecular_function |
| Gene name | ARL6IP5 |
| Protein name | PRA1 family protein PRA1 family protein 3 (ADP-ribosylation factor-like protein 6-interacting protein 5) (ARL-6-interacting protein 5) (Aip-5) (Cytoskeleton-related vitamin A-responsive protein) (Dermal papilla-derived protein 11) (GTRAP3-18) (Glutamate transporter EAAC1-interacting protein) (JM5) (Prenylated Rab acceptor protein 2) (Protein JWa) (Putative MAPK-activating protein PM27) |
| Synonyms | HSPC127 PRA2 JWA DERP11 PRAF3 |
| Description | FUNCTION: Regulates intracellular concentrations of taurine and glutamate. Negatively modulates SLC1A1/EAAC1 glutamate transport activity by decreasing its affinity for glutamate in a PKC activity-dependent manner. Plays a role in the retention of SLC1A1/EAAC1 in the endoplasmic reticulum. . |
| Accessions | ENST00000484921.1 F8WF33 F8WF90 C9JQU6 O75915 ENST00000485444.1 ENST00000273258.4 ENST00000478935.1 |